Re: No word on...
|
5
|
Resverlogix Corp.
|
Jul 14, 2021 09:48AM
|
Re: Resverlogix Receives Approval From Health Canada To Proceed With Fabry Disease Clinical Trial With Lead Compound Apabetalone
|
5
|
Resverlogix Corp.
|
May 30, 2017 11:13AM
|
Re: RESVERLOGIX ANNOUNCES PUBLICATION OF KEY APABETALONE STUDY BETONMACE IN THE JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
|
5
|
Resverlogix Corp.
|
Mar 31, 2020 05:52PM
|
Re: And we wait.....
|
5
|
Zenith Epigenetics
|
Jan 31, 2018 05:26PM
|
Re: early report imo
|
5
|
Resverlogix Corp.
|
Jul 03, 2022 06:50PM
|
Re: Alberta
|
5
|
Resverlogix Corp.
|
Mar 03, 2021 11:10AM
|
Re: ASN late breaker and CKD sub-study top-line
|
5
|
Resverlogix Corp.
|
Oct 11, 2019 11:23AM
|
Re: RVX 2019_11_18 Webcast - Detailed Preliminary Results of BETonMACE - Transcript
|
5
|
Resverlogix Corp.
|
Nov 19, 2019 09:38AM
|
Re: At least RVX has a shorter trial timeline than ESPR
|
5
|
Resverlogix Corp.
|
May 06, 2016 03:15PM
|
Re: Strong Movement Today
|
5
|
Resverlogix Corp.
|
Sep 02, 2015 01:53PM
|
Re: Resverlogix Corp. Selected to Present at Cavendish Global Health Impact Forum
|
5
|
Resverlogix Corp.
|
Oct 23, 2015 03:37PM
|
Re: Warrants conversion!
|
5
|
Resverlogix Corp.
|
Nov 28, 2019 06:54PM
|
Resverlogix & Zenith
|
5
|
Resverlogix Corp.
|
May 14, 2015 09:02AM
|
Re: Pascal Soriot
|
5
|
Resverlogix Corp.
|
Jul 13, 2017 10:37AM
|
Re: Give us just one or two NR’s - money, partners & timeframe
|
5
|
Resverlogix Corp.
|
Apr 14, 2021 11:11AM
|
Re: Re-jigging the matrix with Third Eye's involvement
|
5
|
Resverlogix Corp.
|
Apr 12, 2018 02:55PM
|
RVX share price
|
5
|
Resverlogix Corp.
|
Jul 08, 2018 02:25PM
|
Re: Presentation
|
5
|
Resverlogix Corp.
|
Oct 23, 2020 11:29AM
|
Re: First Dosing v "Actively Recruiting" ?
|
5
|
Resverlogix Corp.
|
Nov 11, 2021 11:18AM
|
Re: A small drop in short interest.....
|
5
|
Resverlogix Corp.
|
Oct 21, 2015 11:03AM
|